Post-mortem molecular profiling of three psychiatric disorders
Ryne C. Ramaker,
Kevin M. Bowling,
Brittany N. Lasseigne,
Megan H. Hagenauer,
Andrew A. Hardigan,
Nick S. Davis,
Preston M. Cartagena,
David M Walsh,
Marquis P. Vawter,
Edward G. Jones,
Jack D. Barchas,
Stan J. Watson,
Blynn G Bunney,
William E. Bunney,
Jun Z. Li,
Sara J. Cooper,
Richard M. Myers
Posted 29 Jun 2016
bioRxiv DOI: 10.1101/061416 (published DOI: 10.1186/s13073-017-0458-5)
Posted 29 Jun 2016
Background: Psychiatric disorders are multigenic diseases with complex etiology contributing significantly to human morbidity and mortality. Although clinically distinct, several disorders share many symptoms suggesting common underlying molecular changes exist that may implicate important regulators of pathogenesis and new therapeutic targets. Results: We compared molecular signatures across brain regions and disorders in the transcriptomes of postmortem human brain samples. We performed RNA sequencing on tissue from the anterior cingulate cortex, dorsolateral prefrontal cortex, and nucleus accumbens from three groups of 24 patients each diagnosed with schizophrenia, bipolar disorder, or major depressive disorder, and from 24 control subjects, and validated the results in an independent cohort. The most significant disease differences were in the anterior cingulate cortex of schizophrenia samples compared to controls. Transcriptional changes were assessed in an independent cohort, revealing the transcription factor EGR1 as significantly down regulated in both cohorts and as a potential regulator of broader transcription changes observed in schizophrenia patients. Additionally, broad down regulation of genes specific to neurons and concordant up regulation of genes specific to astrocytes was observed in SZ and BPD patients relative to controls. We also assessed the biochemical consequences of gene expression changes with untargeted metabolomic profiling and identified disruption of GABA levels in schizophrenia patients. Conclusions: We provide a comprehensive post-mortem transcriptome profile of three psychiatric disorders across three brain regions. We highlight a high-confidence set of independently validated genes differentially expressed between schizophrenia and control patients in the anterior cingulate cortex and integrate transcriptional changes with untargeted metabolite profiling.
- Downloaded 970 times
- Download rankings, all-time:
- Site-wide: 11,971 out of 88,847
- In genomics: 1,663 out of 5,669
- Year to date:
- Site-wide: 52,472 out of 88,847
- Since beginning of last month:
- Site-wide: 50,879 out of 88,847
Downloads over time
Distribution of downloads per paper, site-wide
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!